Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) CEO Sells $3,414,000.00 in Stock
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) CEO Nello Mainolfi sold 30,000 shares of Kymera Therapeutics stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $113.80, for a total transaction of $3,414,000.00. Following the transaction, the chief executive officer directly owned 666,568 shares in […]
4 Oct 04:08 · The Cerbat Gem